Indomethacin Patent Expiration
Indomethacin is Used for relieving pain. It was first introduced by Zyla Life Sciences Us Llc
Indomethacin Patents
Given below is the list of patents protecting Indomethacin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Tivorbex | US8734847 | Formulation of indomethacin | Apr 23, 2030 | Genus |
| Tivorbex | US8992982 | Formulation of indomethacin | Apr 23, 2030 | Genus |
| Tivorbex | US9089471 | Formulation of indomethacin | Apr 23, 2030 | Genus |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Indomethacin's patents.
Latest Legal Activities on Indomethacin's Patents
Given below is the list recent legal activities going on the following patents of Indomethacin.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| 7.5 yr surcharge - late pmt w/in 6 mo, Small Entity | 07 Feb, 2023 | US9089471 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 07 Feb, 2023 | US9089471 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 06 Feb, 2023 | US9089471 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 30 Sep, 2022 | US8992982 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 01 Dec, 2021 | US8734847 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 28 Jan, 2019 | US9089471 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 01 Oct, 2018 | US8992982 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 27 Nov, 2017 | US8734847 |
| Application ready for PDX access by participating foreign offices Critical
| 31 Aug, 2015 | US8992982 |
| Application ready for PDX access by participating foreign offices Critical
| 31 Aug, 2015 | US9089471 |
Indomethacin's Family Patents
